Back to Search Start Over

Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy

Authors :
Xindi Zhang
Matthew R. Trendowski
Emma Wilkinson
Mohammad Shahbazi
Paul C. Dinh
Megan M. Shuey
Regeneron Genetics Center
Darren R. Feldman
Robert J. Hamilton
David J. Vaughn
Chunkit Fung
Christian Kollmannsberger
Robert Huddart
Neil E. Martin
Victoria A. Sanchez
Robert D. Frisina
Lawrence H. Einhorn
Nancy J. Cox
Lois B. Travis
M. Eileen Dolan
Source :
Cancer Medicine, Vol 11, Iss 14, Pp 2801-2816 (2022)
Publication Year :
2022
Publisher :
Wiley, 2022.

Abstract

Abstract Purpose Cisplatin is a critical component of first‐line chemotherapy for several cancers, but causes peripheral sensory neuropathy, hearing loss, and tinnitus. We aimed to identify comorbidities for cisplatin‐induced neurotoxicities among large numbers of similarly treated patients without the confounding effect of cranial radiotherapy. Methods Utilizing linear and logistic regression analyses on 1680 well‐characterized cisplatin‐treated testicular cancer survivors, we analyzed associations of hearing loss, tinnitus, and peripheral neuropathy with nongenetic comorbidities. Genome‐wide association studies and gene‐based analyses were performed on each phenotype. Results Hearing loss, tinnitus, and peripheral neuropathy, accounting for age and cisplatin dose, were interdependent. Survivors with these neurotoxicities experienced more hypertension and poorer self‐reported health. In addition, hearing loss was positively associated with BMIs at clinical evaluation and nonwork‐related noise exposure (>5 h/week). Tinnitus was positively associated with tobacco use, hypercholesterolemia, and noise exposure. We observed positive associations between peripheral neuropathy and persistent vertigo, tobacco use, and excess alcohol consumption. Hearing loss and TXNRD1, which plays a key role in redox regulation, showed borderline significance (p = 4.2 × 10−6) in gene‐based analysis. rs62283056 in WFS1 previously found to be significantly associated with hearing loss (n = 511), was marginally significant in an independent replication cohort (p = 0.06; n = 606). Gene‐based analyses identified significant associations between tinnitus and WNT8A (p = 2.5 × 10−6), encoding a signaling protein important in germ cell tumors. Conclusions Genetics variants in TXNRD1 and WNT8A are notable risk factors for hearing loss and tinnitus, respectively. Future studies should investigate these genes and if replicated, identify their potential impact on preventive strategies.

Details

Language :
English
ISSN :
20457634
Volume :
11
Issue :
14
Database :
Directory of Open Access Journals
Journal :
Cancer Medicine
Publication Type :
Academic Journal
Accession number :
edsdoj.44f25d0b9c9c44fea27f757e2ecf0dda
Document Type :
article
Full Text :
https://doi.org/10.1002/cam4.4644